BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26771976)

  • 1. Diagnostic Value of Serological Tests Against Verotoxigenic Escherichia coli in Hemolytic Uremic Syndrome in Children.
    Leszczyńska B; Ziółkowska H; Podsiadły E; Szych J; Rastawicki W; Demkow U; Roszkowska-Blaim M
    Adv Clin Exp Med; 2015; 24(6):1031-6. PubMed ID: 26771976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of usefulness of the enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to lipopolysaccharides of Enterohemorrhagic Escherichia coli (EHEC) strains in patients with gastrointestinal disorders and patients with hemolytic uremic syndrome].
    Med Dosw Mikrobiol; 2014; 66(3-4):161-75. PubMed ID: 25804070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic.
    Bielaszewska M; Janda J; Blahová K; Feber J; Potuzník V; Soucková A
    Clin Nephrol; 1996 Jul; 46(1):42-4. PubMed ID: 8832150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of usefulness of the enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to lipopolysaccharides of VTEC strains in patients suspected for Escherichia coli O104:H4 infection in Poland].
    Rokosz N; Rastawicki W; Jagielski M
    Med Dosw Mikrobiol; 2011; 63(4):299-304. PubMed ID: 22384662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome.
    Melli LJ; Ciocchini AE; Caillava AJ; Vozza N; Chinen I; Rivas M; Feldman MF; Ugalde JE; Comerci DJ
    J Clin Microbiol; 2015 Feb; 53(2):528-38. PubMed ID: 25472487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome.
    Ludwig K; Grabhorn E; Bitzan M; Bobrowski C; Kemper MJ; Sobottka I; Laufs R; Karch H; Müller-Wiefel DE
    Pediatr Res; 2002 Aug; 52(2):307-13. PubMed ID: 12149511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serological response to Verocytotoxigenic Escherichia coli in patients with haemolytic uraemic syndrome.
    Chart H; Perry NT
    Lett Appl Microbiol; 2004; 38(5):351-4. PubMed ID: 15059202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome.
    Chart H; Smith HR; Scotland SM; Rowe B; Milford DV; Taylor CM
    Lancet; 1991 Jan; 337(8734):138-40. PubMed ID: 1670788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1.
    Karmali MA; Petric M; Winkler M; Bielaszewska M; Brunton J; van de Kar N; Morooka T; Nair GB; Richardson SE; Arbus GS
    J Clin Microbiol; 1994 Jun; 32(6):1457-63. PubMed ID: 8077389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. The HUS Italian Study Group.
    Caprioli A; Luzzi I; Rosmini F; Pasquini P; Cirrincione R; Gianviti A; Matteucci MC; Rizzoni G
    J Infect Dis; 1992 Jul; 166(1):154-8. PubMed ID: 1607689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives.
    Stenger KO; Windler F; Karch H; von Wulffen H; Heesemann J
    Clin Nephrol; 1988 Mar; 29(3):153-8. PubMed ID: 3282732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibodies to verotoxin-producing Escherichia coli (VTEC) strains in patients with haemolytic uraemic syndrome.
    Kishore K; Rattan A; Bagga A; Srivastava RN; Nath NM; Shriniwas
    J Med Microbiol; 1992 Dec; 37(6):364-7. PubMed ID: 1460654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli 'O' group serological responses and clinical correlations in epidemic HUS patients.
    Kulkarni H; Goldwater PN; Martin A; Bettelheim KA
    Comp Immunol Microbiol Infect Dis; 2002 Jul; 25(4):249-68. PubMed ID: 12135239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verocytotoxin-producing Escherichia coli infection in household members of children with hemolytic-uremic syndrome in The Netherlands.
    Heuvelink AE; Van de Kar NC; Van Der Velden TJ; Chart H; Monnens LA
    Pediatr Infect Dis J; 1999 Aug; 18(8):709-14. PubMed ID: 10462341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
    Mody RK; Luna-Gierke RE; Jones TF; Comstock N; Hurd S; Scheftel J; Lathrop S; Smith G; Palmer A; Strockbine N; Talkington D; Mahon BE; Hoekstra RM; Griffin PM
    Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of verocytotoxin from stool and serological testing of patients with diarrhea caused by Escherichia coli O157 : H7.
    Yamada S; Matsushita S; Kai A; Sasaki M; Tsuji A; Kanemitsu T; Yamashita N; Anzai E; Kudoh Y
    Microbiol Immunol; 1993; 37(2):111-8. PubMed ID: 8502176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of verotoxigenic Escherichia coli O157:H7 incidence in gastroenteritis patients].
    Erdoğan H; Levent B; Erdoğan A; Güleşen R; Arslan H
    Mikrobiyol Bul; 2011 Jul; 45(3):519-25. PubMed ID: 21935785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to non-O157 Vero toxin-producing Escherichia coli in patients with hemolytic uremic syndrome.
    Ludwig K; Bitzan M; Zimmermann S; Kloth M; Ruder H; Müller-Wiefel DE
    J Infect Dis; 1996 Nov; 174(5):1028-39. PubMed ID: 8896505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects.
    Greatorex JS; Thorne GM
    J Clin Microbiol; 1994 May; 32(5):1172-8. PubMed ID: 8051241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.